Cargando…
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
Placenta-specific 1 (PLAC1) is expressed primarily in placental trophoblasts but not in normal tissues and is a targetable candidate for cancer immunotherapy because it is a cancer testis antigen known to be up-regulated in various tumors. Although peptide epitopes capable of stimulating CD8 T cells...
Autores principales: | Hayashi, Ryusuke, Nagato, Toshihiro, Kumai, Takumi, Ohara, Kenzo, Ohara, Mizuho, Ohkuri, Takayuki, Hirata-Nozaki, Yui, Harabuchi, Shohei, Kosaka, Akemi, Nagata, Marino, Yajima, Yuki, Yasuda, Syunsuke, Oikawa, Kensuke, Kono, Michihisa, Kishibe, Kan, Takahara, Miki, Katada, Akihiro, Hayashi, Tatsuya, Celis, Esteban, Harabuchi, Yasuaki, Kobayashi, Hiroya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781841/ https://www.ncbi.nlm.nih.gov/pubmed/33457076 http://dx.doi.org/10.1080/2162402X.2020.1856545 |
Ejemplares similares
-
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
por: Kono, Michihisa, et al.
Publicado: (2022) -
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
por: Hirata-Nozaki, Yui, et al.
Publicado: (2019) -
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
por: Kosaka, Akemi, et al.
Publicado: (2021) -
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021) -
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
por: Kono, Michihisa, et al.
Publicado: (2022)